SCHEMBL28903853

SCHEMBL28903853

COc1ncccc1-c1cnn2ccc(N(C)CCCOC(C)(C)C)nc12

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AAK1 Q2M2I8 1/20 0.45
▸ DYRK1A Q13627 2/20 0.38
▸ FYN P06241 1/20 0.36
▸ FFAR4 Q5NUL3 1/20 0.36
▸ SMPD3 Q9NY59 3/20 0.36
▸ JAK2 O60674 4/20 0.35
▸ JAK3 P52333 4/20 0.35
▸ PTK2 Q05397 4/20 0.35
▸ ALOX5AP P20292 1/20 0.35
▸ CSNK2A1 P68400 2/20 0.34
▸ PSEN1 P49768 1/20 0.34
▸ PSEN2 P49810 1/20 0.34
▸ APH1B Q8WW43 1/20 0.34
▸ NCSTN Q92542 1/20 0.34
▸ APH1A Q96BI3 1/20 0.34
▸ PSENEN Q9NZ42 1/20 0.34
▸ CSNK2A2 P19784 1/20 0.34
▸ ACVR2A P27037 1/20 0.32
▸ TGFBR1 P36897 1/20 0.32
▸ TGFBR2 P37173 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28903935 0.87 SMPD3 (0.39) AAK1DYRK1ASMPD3CSNK2A1CSNK2A2
SCHEMBL31677677 0.85 AAK1 (0.48) AAK1FYNFFAR4SMPD3JAK2
SCHEMBL20081018 0.84 AAK1 (0.50) AAK1FYNSMPD3JAK2JAK3
SCHEMBL29660254 0.79 AAK1 (0.56) AAK1FYNFFAR4SMPD3JAK2
SCHEMBL29660313 0.77 AAK1 (0.58) AAK1FYNFFAR4SMPD3JAK2
SCHEMBL19466908 0.75 AAK1 (0.49) AAK1DYRK1AFFAR4CSNK2A1CSNK2A2
SCHEMBL29660359 0.75 AAK1 (0.47) AAK1FYNFFAR4JAK2JAK3
SCHEMBL31441708 0.72 RET (0.47) AAK1FYNJAK2JAK3PTK2
SCHEMBL16553421 0.72 AAK1 (0.49) AAK1FYNFFAR4JAK2JAK3
SCHEMBL23931668 0.72 AAK1 (0.72) AAK1JAK2JAK3PTK2CSNK2A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115427045-A 4- (3- (pyridin-3-yl) pyrazolo [1,5-a ] pyrimidin-5-yl) piperazine for the treatment of COV-229E or COV-OC43 coronavirus infection 莱西肯医药有限公司 2022-12-02 — — CN disclosed
Send feedback